| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 05/15/2001 | US6232299 Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy |
| 05/15/2001 | US6231536 Method and compositions for treatments of cancers |
| 05/10/2001 | WO2001032211A2 Conjugate compounds for treating atheroma and other diseases |
| 05/10/2001 | WO2001032210A2 Compositions for treating atheroma and neoplastic tissue |
| 05/10/2001 | WO2001032154A2 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 05/10/2001 | WO2001032070A2 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 05/10/2001 | CA2389849A1 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 05/09/2001 | EP1096956A1 Intracellular sensitizers for sonodynamic therapy |
| 05/08/2001 | US6228656 Irradiating solution of spermine and triple helix dna which is double-stranded target dna hybridized with single-stranded oligonucleotide probe labeled with intercalator using light having the absorption wavelength of intercalator |
| 05/08/2001 | US6228365 Antitumor agents for pulmonary tumors |
| 05/08/2001 | US6228362 Boron neutron capture therapy using pre-targeting methods |
| 05/03/2001 | WO2001030397A2 Ultrasound inducement of artial and ventricular rhythms |
| 05/03/2001 | WO2000056774A8 Methods of using bioelastomers |
| 05/02/2001 | EP1094843A1 Targeted site specific drug delivery compositions and method of use |
| 05/02/2001 | EP1094840A1 Use of texaphyrins in macrophage-mediated disease |
| 05/02/2001 | EP1094839A1 FARNESYL PROTEIN TRANSFERASE INHIBITORS WITH $i(IN VIVO) RADIOSENSITIZING PROPERTIES |
| 05/02/2001 | EP1094838A1 Retarding tumor angiogenesis related growth |
| 05/02/2001 | EP0966427B1 Preparation of acid amides and metallisation of compounds |
| 05/01/2001 | US6225333 Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| 05/01/2001 | US6225303 Use of green porphyrins to treat neovasculature in the eye |
| 05/01/2001 | US6225296 Inhibitory effects of synthetic and natural colorant on carcinogenesis VIII |
| 05/01/2001 | US6224848 Pharmaceuticals providing diagnosis and selective tissue necrosis using Mossbauer absorber atom |
| 04/26/2001 | DE19950933A1 Use of St. John's wort constituents for photodynamic diagnosis and/or therapy of mouth and malignant brain disorders |
| 04/19/2001 | WO2001026704A2 Targeted drug activation |
| 04/19/2001 | WO2001026684A2 Method for treating hypoxic cells |
| 04/19/2001 | WO2001026676A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | WO2000073308A3 Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production |
| 04/19/2001 | WO2000007514A9 Treatment of pigmented tissues using optical energy |
| 04/19/2001 | CA2387545A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/18/2001 | EP1091758A1 Method for activating an inactive solution |
| 04/18/2001 | EP1091742A1 Indium photosensitizers for pdt |
| 04/18/2001 | EP0935462A4 Photopheresis treatment of leukocytes |
| 04/17/2001 | US6218100 Eliminating viral disease transmission through blood products via said compositions which have ability to inactivate pathogens in presence of ultaviolet light without effecting blood product functioning or exhibiting mutagenicity |
| 04/17/2001 | US6217867 Administering radiation; monoclonal antibodies |
| 04/17/2001 | US6217848 Dye-peptide complex |
| 04/12/2001 | WO2001025404A1 Methods for inhibiting osteoclast formation or methods for inhibiting bone resorption |
| 04/12/2001 | WO2001024825A2 Significance of dosimetry in photodynamic therapy of injured arteries |
| 04/12/2001 | WO2001024824A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/12/2001 | WO2001024705A1 Improved methods for delivering bioactive agents |
| 04/12/2001 | WO2001024684A2 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/12/2001 | CA2699662A1 Rhodamine derivatives for photodynamic diagnosis, prevention and treatment of immunologic disorders |
| 04/12/2001 | CA2386374A1 Methods for treatment of solid tumors and metastasis by gene therapy |
| 04/12/2001 | CA2354043A1 Methods for inhibiting osteoclast formation or methods for inhibiting bone resorption |
| 04/11/2001 | EP1090006A1 Alkyl ether analogs of chlorins having an n-substituted imide ring |
| 04/11/2001 | EP1089788A1 Sonophoresis method and apparatus |
| 04/11/2001 | EP1089786A1 A device for protection against the sun and application of substance to the skin |
| 04/11/2001 | EP1089767A1 Method of inactivating viruses |
| 04/10/2001 | US6214534 Deactivator of free radical associations; for the prevention of transfusion-associated graft-versus-host disease |
| 04/10/2001 | US6214300 Apparatus for making microcapsules, encapsulating pharmaceutical compounds in microcapsules, microcapsules, microcapsule encapsulated pharmaceutical compositions and products; drug delivery |
| 04/05/2001 | WO2000045857A3 Metal macrocycles for two-step forms of radiotherapy |
| 04/04/2001 | EP1087794A2 Utilization of 5-aminolevulinic acid or a derivative thereof for photodynamic diagnosis or photodynamic therapy of diseases of the parodontium and teeth |
| 04/04/2001 | EP1087793A2 Material for differently modifying the optical properties of different cells |
| 04/04/2001 | EP1087717A1 Improved methods and apparatus for multi-photon photo-activation of therapeutic agents |
| 04/03/2001 | US6211355 Reacting cobalamin compound with chelating compound to compound useful for in vivo imaging of organs and tumors |
| 04/03/2001 | US6211191 Integrin receptor antagonists |
| 04/03/2001 | US6210941 Methods for the detection and isolation of proteins |
| 04/03/2001 | US6210672 Topical immunostimulation to induce Langerhans cell migration |
| 04/03/2001 | US6210356 Ultrasound assembly for use with a catheter |
| 04/03/2001 | CA2149636C Method of activating photosensitive agents |
| 03/29/2001 | WO2001021728A1 Fluorescent film |
| 03/28/2001 | EP1085902A2 Therapeutic compositions that produce an immune response by altering the antigen |
| 03/28/2001 | EP1027098A4 Electrically activated substance and method for making the same |
| 03/28/2001 | EP0910428A4 Photopheresis treatment of chronic hcv infections |
| 03/27/2001 | US6207821 Long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis |
| 03/27/2001 | US6207660 Texaphyrin conjugates and uses thereof |
| 03/27/2001 | CA2007499C Treatment methods and vaccines for stimulating an immune response |
| 03/21/2001 | EP1084454A1 Free-form nanofabrication using multi-photon excitation |
| 03/21/2001 | EP1084145A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 03/21/2001 | EP1083881A2 Liposome composition and method for administering a quinolone |
| 03/15/2001 | WO2001017992A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | WO2001017561A1 Fluorescent dye angiography and dye-enhanced photocoagulation |
| 03/14/2001 | EP1082419A2 Combination therapy using nucleic acids and conventional drugs |
| 03/14/2001 | EP1082418A2 Combination therapy using nucleic acids and radio therapy |
| 03/14/2001 | EP1082142A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 03/14/2001 | EP1082138A1 Texaphyrin conjugates and uses thereof |
| 03/14/2001 | EP0980202A4 Methods for viral inactivation and compositions for use in same |
| 03/13/2001 | US6200754 Inhibitors of alternative alleles of genes encoding products that mediate cell response to environmental changes |
| 03/08/2001 | WO2001016347A1 The hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from panax ginseng |
| 03/08/2001 | WO2001015745A1 Method and formula for tumor remission and suppression of cancer |
| 03/08/2001 | WO2001015694A1 Extended duration light activated cancer therapy |
| 03/08/2001 | WO2000038786A3 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 03/08/2001 | CA2391844A1 Method and formula for tumor remission and suppression of cancer |
| 03/08/2001 | CA2382345A1 Extended duration light activated cancer therapy |
| 03/07/2001 | EP1079918A1 Microencapsulation and electrostatic processing method |
| 03/07/2001 | EP1079875A2 Method and compositions for treatment of cancers |
| 03/07/2001 | EP1079824A1 Triterpene compositions and methods for use thereof |
| 03/06/2001 | US6197345 Thrombolytic agents and methods of treatment for thrombosis |
| 03/01/2001 | WO2001013949A2 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077686A1 Externally triggered microcapsules |
| 02/27/2001 | US6194139 Using a psoralen compound |
| 02/27/2001 | US6193951 Microparticles useful as ultrasonic contrast agents |
| 02/22/2001 | WO2001012263A2 Dosimetry for californium-252 brachytherapy sources and encapsulation, storage, and clinical delivery thereof |
| 02/22/2001 | WO2001012217A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 02/22/2001 | WO2001012181A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 02/22/2001 | WO2001012071A1 Microparticles useful as ultrasonic contrast agents and for lymphatic system |
| 02/22/2001 | WO2001012069A1 Hollow microspheres with controlled fragility for medical use |
| 02/22/2001 | WO2000062808A3 Cobalamin conjugates useful as antitumor agents |
| 02/22/2001 | WO2000062788A3 Treatment of hypersensitivity reaction disorders |
| 02/22/2001 | DE19940220A1 Preparation for treating rheumatic joint diseases, e.g. arthritis, comprising injectable, induction heatable, iron oxide-based magnetic particles including radionuclide and cytotoxic agent |